China SXT Pharmaceuticals, Inc. (SXTC)

NASDAQ: SXTC · IEX Real-Time Price · USD
1.89
-0.06 (-2.83%)
May 26, 2022 3:59 PM EDT - Market closed

Cash Flow Statement (Annual)

Millions USD. Fiscal year is Apr - Mar.
Year20202019201820172016
Net Income
-2.75-10.291.541.191.19
Depreciation & Amortization
0.350.330.180.130.1
Other Operating Activities
1.0910.89-1.480.6-0.99
Operating Cash Flow
-1.320.930.241.920.29
Operating Cash Flow Growth
-290.58%-87.54%555.25%-
Capital Expenditures
-0.09-0.41-0.6-1.03-0.18
Acquisitions
3.13-3.59000
Change in Investments
-8.85-1.5000
Other Investing Activities
00-0.01-0.02-0.01
Investing Cash Flow
-5.81-5.5-0.61-1.05-0.19
Share Issuance / Repurchase
006.4900
Debt Issued / Paid
-0.126.720.07-0.31-0.05
Other Financing Activities
12.53-3.72.4800
Financing Cash Flow
12.413.029.04-0.31-0.05
Net Cash Flow
6.07-28.630.590.05
Free Cash Flow
-1.410.53-0.360.890.11
Free Cash Flow Growth
---682.03%-
Free Cash Flow Margin
-159.28%159.67%-169.51%67.61%15.57%
Free Cash Flow Per Share
-1.961.71-1.403.560.46
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).